![]() |
Name |
Aspergillussanone C
|
Molecular Formula | C35H44O10 | |
IUPAC Name* |
2,4,6,9-tetrahydroxy-2-[9-[2-hydroxy-6-(2-hydroxypropan-2-yl)-1,7-dioxaspiro[2.5]octan-8-yl]-3,7-dimethylnona-2,6-dienyl]-5,7-dimethylphenalene-1,3-dione
|
|
SMILES |
CC(=CCC1(O)C(=O)c2c(O)cc(C)c3c(O)c(C)c(O)c(c23)C1=O)CCC=C(C)CCC1OC(C(C)(C)O)CCC12OC2O
|
|
InChI |
InChI=1S/C35H44O10/c1-17(10-11-23-35(32(41)45-35)15-13-22(44-23)33(5,6)42)8-7-9-18(2)12-14-34(43)30(39)25-21(36)16-19(3)24-26(25)27(31(34)40)29(38)20(4)28(24)37/h8,12,16,22-23,32,36-38,41-43H,7,9-11,13-15H2,1-6H3/b17-8+,18-12+/t22-,23-,32+,34-,35+/m0/s1
|
|
InChIKey |
SAOZIHRXOILDER-XZESFQPPSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 624.73 | ALogp: | 4.9 |
HBD: | 6 | HBA: | 10 |
Rotatable Bonds: | 9 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 177.3 | Aromatic Rings: | 5 |
Heavy Atoms: | 45 | QED Weighted: | 0.122 |
Caco-2 Permeability: | -5.03 | MDCK Permeability: | 0.00000849 |
Pgp-inhibitor: | 0.443 | Pgp-substrate: | 0.922 |
Human Intestinal Absorption (HIA): | 0.948 | 20% Bioavailability (F20%): | 0.935 |
30% Bioavailability (F30%): | 0.187 |
Blood-Brain-Barrier Penetration (BBB): | 0.033 | Plasma Protein Binding (PPB): | 96.51% |
Volume Distribution (VD): | 1.352 | Fu: | 3.83% |
CYP1A2-inhibitor: | 0.038 | CYP1A2-substrate: | 0.259 |
CYP2C19-inhibitor: | 0.026 | CYP2C19-substrate: | 0.326 |
CYP2C9-inhibitor: | 0.175 | CYP2C9-substrate: | 0.157 |
CYP2D6-inhibitor: | 0.12 | CYP2D6-substrate: | 0.125 |
CYP3A4-inhibitor: | 0.25 | CYP3A4-substrate: | 0.272 |
Clearance (CL): | 4.005 | Half-life (T1/2): | 0.034 |
hERG Blockers: | 0.006 | Human Hepatotoxicity (H-HT): | 0.345 |
Drug-inuced Liver Injury (DILI): | 0.481 | AMES Toxicity: | 0.791 |
Rat Oral Acute Toxicity: | 0.095 | Maximum Recommended Daily Dose: | 0.793 |
Skin Sensitization: | 0.445 | Carcinogencity: | 0.96 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.007 |
Respiratory Toxicity: | 0.493 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005339 | ![]() |
0.769 | D03VFL | ![]() |
0.253 | ||
ENC005338 | ![]() |
0.767 | D0FX2Q | ![]() |
0.252 | ||
ENC003495 | ![]() |
0.732 | D0G4OD | ![]() |
0.250 | ||
ENC005340 | ![]() |
0.700 | D0WY9N | ![]() |
0.246 | ||
ENC005341 | ![]() |
0.631 | D0Q0PR | ![]() |
0.232 | ||
ENC003114 | ![]() |
0.623 | D0G3DL | ![]() |
0.229 | ||
ENC003842 | ![]() |
0.615 | D02GAC | ![]() |
0.225 | ||
ENC003496 | ![]() |
0.615 | D01XWG | ![]() |
0.225 | ||
ENC003494 | ![]() |
0.585 | D04VEJ | ![]() |
0.224 | ||
ENC002960 | ![]() |
0.331 | D05CHI | ![]() |
0.223 |